Common Reasons Youre Not Experiencing Weight Loss on Semaglutide If youre not seeing the semaglutide before and after you desired at the start of your journey, that doesnt mean its impossible
Tirzepatide is not recommended for use in patients with type I diabetes
The obesity drug market is entering new phases, which includes Eli Lilly and Company advancing retatrutide, a next-generation triple-G therapy that could outperform its own marketed dual agonist Zepbound (tirzepatide)
Everybody responds differently. Lilly's Triple Agonist, Retatrutide, Successful in Two Additional Phase 3 Obesity Trials, Delivering Significant Improvements in Weight and A1C
Heres why: For many patients on GLP-1 medications, proton pump inhibitors (PPIs) have emerged as the most effective solution for managing persistent heartburn
The FDA has prohibited the use of BPC-157 in compounding semaglutide